These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 25380654)

  • 1. Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients.
    Qiu M; Zhou Y; Zhang X; Wang Z; Wang F; Shao J; Lu J; Jin Y; Wei X; Zhang D; Wang F; Li Y; Yang D; Xu R
    BMC Cancer; 2014 Nov; 14():823. PubMed ID: 25380654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
    He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
    World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological Variation of Lauren Classification in Gastric Cancer.
    Chen YC; Fang WL; Wang RF; Liu CA; Yang MH; Lo SS; Wu CW; Li AF; Shyr YM; Huang KH
    Pathol Oncol Res; 2016 Jan; 22(1):197-202. PubMed ID: 26502923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of Human epidermal growth factor receptor-2 expression in patients with resectable gastric adenocarcinoma.
    Kim H; Seo S; Kim K; Park YH; An M; Baik H; Choi C; Oh S
    World J Surg Oncol; 2019 Jul; 17(1):122. PubMed ID: 31296222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of major receptor tyrosine kinase expression in gastric cancer.
    Kurokawa Y; Matsuura N; Kawabata R; Nishikawa K; Ebisui C; Yokoyama Y; Shaker MN; Hamakawa T; Takahashi T; Takiguchi S; Mori M; Doki Y
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S584-90. PubMed ID: 24743909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiology of the two types of gastric adenocarcinoma in Iceland according to the Laurén histological classification 1990-2009].
    Olafsdottir HS; Alexiusdottir KK; Lund SH; Jonasson JG; Jonsson T; Skuladottir H
    Laeknabladid; 2016 Mar; 102(3):125-30. PubMed ID: 26985590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both GLUT-1 and GLUT-14 are Independent Prognostic Factors in Gastric Adenocarcinoma.
    Berlth F; Mönig S; Pinther B; Grimminger P; Maus M; Schlösser H; Plum P; Warnecke-Eberz U; Harismendy O; Drebber U; Bollschweiler E; Hölscher A; Alakus H
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S822-31. PubMed ID: 26183839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor efficacy response to trastuzumab therapy in advanced gastric cancer with homogeneous HER2 positive and non-intestinal type.
    Xu C; Liu Y; Jiang D; Li Q; Ge X; Zhang Y; Huang J; Su J; Ji Y; Hou J; Lu S; Hou Y; Liu T
    Oncotarget; 2017 May; 8(20):33185-33196. PubMed ID: 28388541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of Laurén classification and c-erbB-2 oncogene overexpression in adenocarcinoma of the esophagus and gastroesophageal junction.
    Polkowski W; van Sandick JW; Offerhaus GJ; ten Kate FJ; Mulder J; Obertop H; van Lanschot JJ
    Ann Surg Oncol; 1999; 6(3):290-7. PubMed ID: 10340889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in China.
    Qiu MZ; Cai MY; Zhang DS; Wang ZQ; Wang DS; Li YH; Xu RH
    J Transl Med; 2013 Mar; 11():58. PubMed ID: 23497313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
    He XX; Ding L; Lin Y; Shu M; Wen JM; Xue L
    J Clin Pathol; 2015 May; 68(5):374-80. PubMed ID: 25731189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between HER2 expression and tumor interstitial angiogenesis in primary gastric cancer and its effect on prognosis.
    Li F; Meng G; Tan B; Chen Z; Ji Q; Wang X; Liu C; Niu S; Li Y; Liu Y
    Pathol Res Pract; 2021 Jan; 217():153280. PubMed ID: 33253925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Integration and analysis of associated data in surgical treatment of gastric cancer based on multicenter, high volume databases].
    Wang W; Sun Z; Deng J; Wang Z; Zhou Z; Liang H; Xu H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Feb; 19(2):179-85. PubMed ID: 26831882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Helicobacter Pylori associated with Her2/neu Overexpression in Gastric Cancer Patients who Underwent Curative Resection?
    Yoo MW; Han HS; Kim SY; Cho YH; Lee HG; Kim JH; Bang HY; Lee KY; Yoon SY
    Hepatogastroenterology; 2014 May; 61(131):858-62. PubMed ID: 26176087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic significance of the Lauren classification of patients with stomach carcinoma. A statistical analysis of long-term results following gastrectomy].
    Roukos D; Lorenz M; Hottenrott C
    Schweiz Med Wochenschr; 1989 May; 119(21):755-9. PubMed ID: 2756405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in HER2 over-expression between proximal and distal gastric cancers in the Chinese population.
    Fan XS; Chen JY; Li CF; Zhang YF; Meng FQ; Wu HY; Feng AN; Huang Q
    World J Gastroenterol; 2013 Jun; 19(21):3316-23. PubMed ID: 23745034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and significance of IGF-2, PCNA, MMP-7, and α-actin in gastric carcinoma with Lauren classification.
    Kuang RG; Wu HX; Hao GX; Wang JW; Zhou CJ
    Turk J Gastroenterol; 2013; 24(2):99-108. PubMed ID: 23934455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of HER2 status with prognosis in gastric cancer patients undergoing R0 resection: A large-scale multicenter study in China.
    Shen GS; Zhao JD; Zhao JH; Ma XF; Du F; Kan J; Ji FX; Ma F; Zheng FC; Wang ZY; Xu BH
    World J Gastroenterol; 2016 Jun; 22(23):5406-14. PubMed ID: 27340357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic analysis of patients with operable gastric cancer and tolerability to adjuvant radio-chemo-therapy.
    Kucukoner M; Arpaci E; Isikdogan A; Bilici M; Uncu D; Cetin B; Dane F; Inanc M; Ekinci AS; Inal A; Cayir K; Yetisyigit T; Ozdemir N; Kaplan MA; Aksoy S; Alkıs N; Tekin SB; Eroglu C; Turhal S; Buyukberber S
    Neoplasma; 2013; 60(1):19-25. PubMed ID: 23067212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Clinicopathologic Features and Prognostic Impact of ALK Positivity in Patients with Resected Gastric Cancer.
    Chon HJ; Kim HR; Shin E; Kim C; Heo SJ; Lee CK; Park JK; Noh SH; Chung HC; Rha SY
    Ann Surg Oncol; 2015 Nov; 22(12):3938-45. PubMed ID: 25707491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.